Pharmaceuticals, Biotechnology and Life Sciences
U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…
DUBLIN–(BUSINESS WIRE)–The “Cryptosporidiosis Global Clinical Trials Review, H1, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. Cryptosporidiosis Global Clinical…
Third party research conducted by leading U.S. institutions to be published in a peer reviewed journal Crohn’s & Colitis 360…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Osteoarthritis” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Osteoarthritis market,…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Migraine” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Migraine market,…
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute GvHD with no safety concerns occurring within the study—
Vladislav Sandler, Chief Executive Officer of Hemogenyx Pharmaceuticals, said the potential of the ApbHC, a new generation of our humanized mice, which has allowed the company to rapidly obtain in vivo data on the efficacy of the company’s CDX antibodies against AML.
Evgen Pharma’s lead product, SFX-01, has been featured in a recently published paper, in the journal “Oxidative Medicine and Cellular Longevity”, describing Phase IIb trial in subarachnoid haemorrhage (“SAH”) at University Hospital Southampton.
EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.